explore -WSS

explore

author：hotspot 2025-08-04 03:41:57 - browse：62649

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

WSS

A rare thyroid diagnosis led to unexpected, all

The 10 drugs up first for Medicare price negotiation

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Google says AlphaFold 3 can map a vast universe of biomolecules

CDC wastewater surveillance dashboard to track bird flu hotspots

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Wikipedia

explore

entertainment

Supreme Court strikes down use of affirmative action

Readout LOUD podcast: What to know about H5N1 bird flu

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A new House health package & hospitals’ new site

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: What to know about H5N1 bird flu

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Walensky prepares to leave CDC — and Congress — behind

A rare thyroid diagnosis led to unexpected, all

explore

After gene therapy, two congenitally deaf children hear for the first time

After gene therapy, two congenitally deaf children hear for the first time

Advances in CAR

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Brain worms: The science behind RFK Jr.'s parasitic infection

Study: AI not yet building 'n

explore

hotspot

hotspot

entertainment